Dr. Cooper is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
160 E 34th Street
New York, NY 10016
Summary
- My primary research focus is improving clinical outcomes in patients during the difficult time following a cancer diagnosis. Two of the major areas I focus my research efforts on are improving patient reported quality of life and attempting to understand every individual's cancer on a molecular level. Clinicians often focus on objective measures of treatment success such as local recurrence and disease-free survival. While these are certainly important endpoints, and often the primary objective of the clinical trials we conduct here at NYU Langone Medical Center, it is equally important to ensure we consider the emotional and physical cost our treatments have on our patients. To measure this effect, I strive to capture the patient voice in clinical trials conducted here at NYU Langone Medical Center with validated quality of life questionnaires.
With advances in technology we are understanding cancer on a molecular level better than ever before. I collaborate with laboratory based scientists with a deep knowledge of the inner workings of the cellular mechanics to gain a more robust understanding of the genetics and epigenetics of an individual’s tumor to drive therapy and inform future clinical trials. Using the Illumina Methylation Array platform we are able to uncover the specific genetic information of individual tumors that can accelerate the understanding of tumor behavior, and ultimately improve patient outcomes.
Education & Training
- NYU Grossman School of MedicineResidency, Radiation Oncology, 2012 - 2016
- Lewis Katz School of Medicine at Temple UniversityClass of 2011, MD, AOA
- Penn State UniversityB.S., Bioengineering, Chemical Engineering, Cum Laude, 2003 - 2007
Certifications & Licensure
- NY State Medical License 2016 - 2026
- NJ State Medical License 2016 - 2025
- PA State Medical License 2011 - 2012
- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- Merit Award Recipient Conquer Cancer Foundation of ASCO, 2015
- Radiation Oncology Dedication Award NYU, 2013
- Presentation Finalist (2nd Place – Under 35 Division) American Society for Artificial Internal Organs (ASAIO), 2007
- Join now to see all
Publications & Presentations
PubMed
- 589 citationsRadiotherapy induces responses of lung cancer to CTLA-4 blockadeSilvia C. Formenti, Nils Rudqvist, Encouse B. Golden, Benjamin T. Cooper, Erik Wennerberg
Nature Medicine. 2018-11-05 - 190 citationsCombinations of immunotherapy and radiation in cancer therapy.Ralph E. Vatner, Benjamin T. Cooper, Claire Vanpouille-Box, Sandra Demaria, Silvia C. Formenti
Frontiers in Oncology. 2014-11-28 - 2 citationsLow-Dose Radiosurgery for Brain Metastases in the Era of Modern Systemic Therapy.Juan Diego Alzate, Elad Mashiach, Assaf Berger, Kenneth Bernstein, Reed Mullen
Neurosurgery. 2023-11-01
Journal Articles
- Radiotherapy Induces Responses of Lung Cancer to CTLA-4 BlockadeAbraham Chachoua, Silvia C Formenti, Benjamin Cooper, Kent Friedman, Sandra Demaria, Nature
- The Influence of Operational Protocol on the Fluid Dynamics in the 12 cc Penn State Pulsatile Pediatric Ventricular Assist Device: The Effect of End-Diastolic DelayCooper BT, Roszelle BN, Long TC, Deutsch S, Manning KB, Artif Organs, 1/1/2010
- A Novel Approach to the Correlation of Fluid Dynamics and Thromboembolism Associated with Cardiovascular Prosthetic DevicesCooper BT, Long GD, Knight LC, Manning KB, The 11th International Congress of the IUPESM Medical Physics and Biomedical Engineering World Congress Proceedings, 1/1/2009
- Join now to see all
Abstracts/Posters
- Anal cancer outcomes in patients treated with intensity modulated versus 3-dimensional chemoradiotherapyCooper BT, Grew D, Bitterman D,Sanfilippo NS, Du K, ASCO Gastrointestinal Cancer Symposium, San Francisco, CA, 1/15/2015
- Prospective Randomized Trial of Prone Accelerated Intensity Modulated Whole Breast Radiation Therapy with a Daily Versus Weekly Boost to the Tumor Bed: 3-Year ResultsCooper BT, Formenti-Ujlaki GF, Shin SM, Fenton-Kerimian M, Roses D, Guth A, Jozsef G, DeWyngaert JK, Formenti SC, The 56th Annual American Society of Radiation Oncology Conference, San Francisco, CA, 1/14/2014
- Use of Simultaneous Integrated Boost Regimen with Flexible Inflatable Multi-Channel Versus Virtual Single Channel and Syed Applicator in the Management of Gynecologic ...Shin SM, Duckworth T, Cooper BT, Curtain JP, Schiff PB, Lymberis SC, DeWyngaert JK, The 56th Annual American Society of Radiation Oncology Conference, San Francisco, CA, 1/14/2014
- Join now to see all
Lectures
- 3-Year results of NYU 09-0030 Boost Trial: Daily versus Weekly IMRT Boost to the Tumor BedNew York, NY - 1/1/2015
- Structure Delineation, Contouring and Location of Heart and LAD in the Prone vs. Supine PositionNew York, NY - 1/1/2014
- The Challenges of Developing a Pediatric Venricular Assist Device from a Fluid Dynamics PerspectiveNaples, FL - 1/16/2010
Press Mentions
- CivaTech Oncology and NYU Langone Health Launch NIH-Sponsored Trial to Fight Lung CancerOctober 27th, 2020
- A Feat of Surgical Skill Brings a Patient Back to Life in the ORNovember 6th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: